Effect of age on the development of a latanoprost-induced increase in iris pigmentation.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 17306877.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To study the effect of patient age on the incidence of latanoprost-induced increases in iris pigmentation. Prospective observational observer-masked study. Thirty-six patients younger than 60 years (group 1) and 36 patients older than 75 years (group 2) with primary open-angle glaucoma. We photographed both irises of each patient before and 6 months after unilateral latanoprost therapy. The basal iris colors were matched in both groups. Iris heterochromia identification at the 6-month evaluation of the photographs. Twenty-eight patients (77.78%) in group 2 developed an increase in iris pigmentation compared with eight patients (22.22%) in group 1 (P = 0.0001, chi-square test). Age seems to be an important risk factor for latanoprost-induced iris color change.
Medical subject headings
- Aging
- Eye Color
- Glaucoma, Open-Angle
- Prostaglandins F, Synthetic